Division of Nutrition

8th Annual
Postgraduate Nutrition Symposium

Metabolic Syndrome and Onset of Cancer

March 15 - 16, 2006
Boston

No Webcast recordings are available for this event.


Welcome

W. Allan Walker, M.D.
Conrad Taff Professor of Nutrition;
Director, Division of Nutrition, Harvard Medical School

Introductory Remarks

George Blackburn, M.D., Ph.D.
S. Daniel Abraham Associate Professor of Nutrition;
Associate Director, Division of Nutrition, Harvard Medical School


SESSION I
METABOLIC SYNDROME (MS) AND CANCER RISK:
EPIDEMIOLOGICAL INVESTIGATION

Moderator:
John Milner, Ph.D.
Chief of the Nutrition Science Research Group in the Division of Cancer Prevention
National Cancer Institute

Epidemiological Evidence on MS and Cancer Development:
An Overview of Epidemiological Evidence and Proposed Mechanics

Eugenia E. Calle, Ph.D.
American Cancer Society

The Role of IGF-I Signaling in Cancer Risk and Progression:
A Connection Between MS and Cancer Risk

Michael N. Pollak, M.D., FRCP
McGill University

Diabetes, MS and Risk of Breast Cancer

Karin Michels, Sc.D., Ph.D.,
Brigham and Women's Hospital,
Harvard Medical School

MS, Obesity and Risk of Colon Cancer

Edward L. Giovannucci, D.Sc., M.D.,
Harvard School of Public Health

MS, Obesity and Risk of Prostate Cancer

Ann Hsing, Ph.D.,
National Cancer Institute

Panel Discussion


SESSION II
BASIC RESEARCH

Moderator:
Jin-Rong Zhou, PhD,
Assistant Professor of Surgery, Harvard Medical School;
Director, Nutrition/Metabolism Lab, Beth Israel Deaconess Medical Center

PI3K-Akt: A Central Pathway in Both Turmorigenesis and Insulin Signaling

Lewis C. Cantley, Ph.D.,
Beth Israel Deaconess Medical Center,
Harvard Medical School

The Role of Adiponectin in Cancer Development and Progression

Christos S. Mantzoros, M.D.,
Beth Israel Deaconess Medical Center,
Harvard Medical School

Free Fatty Acids, Insulin Resistance and Cancer

Richard N. Bergman, Ph.D.,
University of Southern California School of Medicine

The Role of AMPK in MS and Cancer

Neil B. Ruderman, M.D.,
Boston University Medical Center

The Potential Role of MS in Epigenetic Modulation of Carcinogenesis

Sharon A. Ross, Ph.D., M.P.H.,
National Cancer Institute

The Role of Stress and Inflammatory Pathways in Metabolic Homeostasis and Survival

Gokhan Hotamisligil, M.D., Ph.D.,
Harvard School of Public Health

Panel Discussion


SESSION III
PREVENTION AND INTERVENTION:
Preclinical and Clinical Studies

Moderator:
George L. Blackburn, M.D, Ph.D.,
S. Daniel Abraham Associate Professor of Nutrition;
Associate Director, Division of Nutrition, Harvard Medical School

Dietary Fat Reduction and Breast Cancer Outcome:
Results from the Women's Intervention Nutrition Study (WINS)

George L. Blackburn, M.D, Ph.D..
Harvard Medical School
Division of Nutrition

Dietary and Nutritional Combinations and Cancer Prevention: Targeting MS

Jin-Rong Zhou, Ph.D.

Insulin Sensitizers and Cancer Prevention and Treatment:
PPAR-gamma Agonists

Bruce Spiegelman, Ph.D.,
Harvard Medical School,
Dana Farber Cancer Institute

Prostate Cancer Prevention by Nutritional Means to Alleviate MS

R. James Barnard, Ph.D.,
UCLA

Panel Discussion


SESSION IV
TRANSLATIONAL AND CLINICAL SCIENCE

WHI Summary and Dietary Implications

John Milner, Ph.D.,
National Cancer Institute

Panel Discussion

Closing Remarks

Dr. Walker and Dr. Blackburn


Presented by
The Division of Nutrition and Harvard Clinical Nutrition Research Center
HARVARD MEDICAL SCHOOL
in conjunction with
The Department of Nutrition
HARVARD SCHOOL OF PUBLIC HEALTH